Bettina Monika Ruppelt

Academic Foundation and Professional Journey

Professor Ruppelt’s robust academic career is anchored by a PhD in Pharmaceutical Sciences, which she earned from the Federal Fluminense University (UFF) in 2010. This rigorous doctoral training provided the foundation for her subsequent impactful work in pharmacology. Following her PhD, she has established herself as a respected Professor of Pharmacology at UFF.

Her commitment to academia extends beyond research into teaching and mentorship. In her role at UFF, she not only advances scientific knowledge but also shapes the next generation of pharmaceutical scientists and healthcare professionals. Therefore, her influence is felt both in the laboratory and in the classroom.

Leadership in Pharmacognosy and Evidence-Based Phytotherapy

A significant aspect of Professor Bettina Monika Ruppelt‘s work is her leadership of a pre-clinical pharmacognosy laboratory. This lab is at the forefront of investigating the therapeutic potential of Brazilian medicinal plants, a field of critical importance given Brazil’s rich biodiversity. Moreover, her research emphasizes an evidence-based approach to phytotherapy, seeking to validate traditional uses through rigorous scientific methodology.

She actively advocates for the inclusion of scientifically proven phytotherapeutic treatments within the SUS. This advocacy is crucial for making effective and safe traditional and complementary medicine accessible to a wider population. Consequently, her efforts contribute to strengthening public health through scientifically grounded integrative practices, resonating with the WCTCIM’s objective of advancing TCIM integration into global public health systems.

Pioneering Research: The Atlantic Forest Flora Patent

A testament to her innovative research is a patent she holds on anti-inflammatory compounds derived from the Atlantic Forest flora. This achievement is particularly noteworthy as it underscores the potential of Brazil’s unique ecosystems to yield novel therapeutic agents. The Atlantic Forest, a biodiversity hotspot, offers a wealth of untapped resources for medical discovery.

This patent not only highlights her scientific acumen but also aligns with the WCTCIM thematic axis “Diversity in the Spectrum of TCIM Modalities Globally – From Codified Traditions to Indigenous Wisdom.” By scientifically investigating and validating compounds from indigenous flora, Professor Ruppelt’s work bridges traditional knowledge with modern pharmaceutical science. Such advancements are pivotal for developing new treatments and promoting planetary health through sustainable use of natural resources. The work by Bettina Monika Ruppelt in this area is vital.

Contributions to Integrative Health Education and Capacity Building

Professor Ruppelt’s dedication to advancing Traditional, Complementary, and Integrative Medicine (TCIM) is further demonstrated by her role as Coordinator of the PICS (Práticas Integrativas e Complementares em Saúde – Integrative and Complementary Health Practices) postgraduate programme. This leadership position is instrumental in developing skilled professionals in the field of integrative health.

The PICS postgraduate programme aims to equip healthcare practitioners with the necessary competencies to apply TCIM effectively and ethically. This initiative directly supports the WCTCIM’s thematic axis “TCIM Education, Training & Capacity Building – Empowering Future Integrative Health Professionals.” By fostering expertise and leadership in PICS, Professor Ruppelt contributes significantly to the sustainable integration of these practices into healthcare systems, thereby enhancing patient care options and promoting holistic well-being. Her efforts ensure that future health professionals are prepared to meet the growing demand for integrative approaches.

Extensive Scholarly Impact: Publications and Scientific Discourse

The breadth and depth of Professor Bettina Monika Ruppelt‘s research are reflected in her extensive list of over 70 published scientific papers. These publications contribute valuable knowledge to the fields of pharmacology, pharmacognosy, and integrative medicine, and are accessible through platforms like PubMed and her ORCID profile.

Her scholarly output demonstrates a sustained commitment to “Grounding Wisdom in Research,” another key thematic axis of the 3rd WCTCIM. Through rigorous investigation and dissemination of findings, she helps build the evidence base for TCIM modalities. This body of work not only advances scientific understanding but also informs clinical practice and health policy, thereby fostering the evidence-informed integration of TCIM into healthcare. Her consistent contributions solidify her reputation as a key researcher in the field.

Professor Ruppelt’s participation as a speaker at the 3rd WCTCIM will provide an excellent opportunity for attendees to learn directly from her extensive experience and research. Her insights into Brazilian medicinal plants, evidence-based phytotherapy, and the development of integrative health education programs will undoubtedly enrich the congress’s discussions and contribute to its overarching goal of strengthening global public health through TCIM.

Explore the research and academic work of Bettina Monika Ruppelt: For further details on her publications and professional activities, please visit her ORCID profile: https://orcid.org/0000-0003-1472-6948 (>70 papers)